Testing the Efficacy and Safety of the WEI Nasal Jet

N/ACompletedNCT02005406

Zeyong Yang49 enrolled

Overview

Testing the efficacy and safety of the WEI Nasal Jet.

This is only initial thought and suggestions from the inventor Dr. Huafeng Wei. Principal investigator from each medical center interested in testing this new device should design their own clinical trials based on patient population and their own ideas for clinical trials. Just remind you that patient safety is number one and try all efforts to minimize patient risks during your clinical study.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Complication of Surgical Procedure

Interventions

Experimental group and control grouplDEVICE

JET

Eligibility

Sex: ALLMin age: 22 YearsMax age: 58 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Patients receiving various types of surgeries under sedation, especially for procedures of colonoscopy, upper gastrointestinal endoscopy, endoscopic retrograde cholangiopancreatography (ERCP) cystoscopy and other brief surgeries you are interested in the study. Exclusion Criteria: * Patients with coagulopathy and tendency of nose bleeding. * Patients with any diagnosed cardiac diseases (e.g. cardiac failure, angina, MI, cardiac arrhythmia. etc.) * Patients with any diagnosed pulmonary disease (e.g. asthma, COPD, pulmonary embolism, pulmonary edema etc.) * Pregnant patients * Patients with liver failure * Patients with kidney failure

Outcomes

Primary Outcomes

lowest SaO2 in Wei JET group

Compare with Control group,there was no significant difference in lowest SaO2 in Wei JET group.

Time frame: 2 second

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.